Back to top
more

Aetna Inc. (AET)

(Delayed Data from NYSE)

$208.05 USD

208.05
1,800,727

-1.47 (-0.70%)

Updated Nov 14, 2018 03:57 PM ET

Add to portfolio

2-Buy   2      

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
25.68%
18.56%
10.1%
5.5%
2.33%
10.82%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

B Value | F Growth | F Momentum | F VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Benjamin Rains

What to Expect from CVS Health's Q3 Earnings

Let's see what to expect from CVS before the opening bell Tuesday.

AMZN AET CVS RAD WBA

Benjamin Rains

Should You Buy CVS Stock Ahead of Q3 Earnings?

Let's see if investors should think about buying CVS stock ahead of its Q3 financial results.

AMZN AAPL AET CVS WBA RAD

Mark Vickery

Top Analyst Reports for Amazon, Facebook, Mastercard & Merck

Today's Research Daily features new research reports on 17 major stocks, including Amazon (AMZN), Facebook (FB), Mastercard (MA) and Merck (MRK).

MRK MA HSBC FB BAX AMZN AET

Zacks Equity Research

Aetna (AET) Q3 Earnings Beat Estimates, Membership Increases

Aetna (AET) earnings grow on revenue and membership gains.

UNH WCG AET CVS

Zacks Equity Research

Aetna (AET) Surpasses Q3 Earnings and Revenue Estimates

Aetna (AET) delivered earnings and revenue surprises of 4.23% and 1.75%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

AET

Zacks Equity Research

What's in the Offing for Aetna (AET) This Earnings Season?

Aetna's (AET) third-quarter earnings to gain from higher revenues, partly offset by increase in expenses.

ANTM HUM AET MOH

Zacks Equity Research

Aetna (AET) Q3 Earnings Preview: How Are Events Shaping Up?

Aetna (AET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AET

Zacks Equity Research

Can Aetna (AET) Keep the Earnings Surprise Streak Alive?

Aetna (AET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

AET

Zacks Equity Research

UnitedHealth's (UNH) Q3 Earnings Beat, 2018 Guidance Raised

UnitedHealth's (UNH) Q3 results gained from higher revenues from both its segments and increase in membership.

AET MOH UNH THC

Zacks Equity Research

Will Optum Aid UnitedHealth Group's (UNH) Q3 Earnings?

Revenue and earnings gains across all the Optum's subsegments should aid UnitedHealth's Q3 earnings.

CI AET MOH UNH

Zacks Equity Research

Will UnitedHealth's (UNH) Revenue Growth Aid Q3 Earnings?

Revenue growth at the company's Optum and United Healthcare segments should drive earnings in Q3.

UNH MOH AET THC

Zacks Equity Research

Honeywell to Enhance Operational Efficiency of Sappi Plant

Honeywell's (HON) technology will be utilized in one of the oldest paper mills in Europe to modernize it under Sappi's project.

HON DHR MIC AET

Zacks Equity Research

Molina Healthcare Sells MMS Unit to Streamline Business

Molina Healthcare (MOH) sells its Medicaid Solutions unit to focus on core operations.

AET MOH UNH DXC

Ritujay Ghosh

Employer Sponsored Health Insurance Premiums Jump: 4 Picks

An increasing number of memberships, with unemployment rate hitting a record low, have been one of the prime factors behind the top-line growth of the health insurance sector.

CI AET MOH HUM

Mark Vickery

Top Research Reports for Adobe, United Technologies & Lockheed Martin

Today's Research Daily features new research reports on 16 major stocks, including Adobe (ADBE), United Technologies (UTX) and Lockheed Martin (LMT).

UTX LMT KO CVS AET ADBE

Zacks Equity Research

Cigna Gets Merger Nod, Forms Management for Unified Entity

Cigna (CI) forms management as it prepares for new merged entity.

CI AET CVS ESRX

Zacks Equity Research

WellCare Health's (WCG) Buyout to Expand Medicare Business

WellCare Health's (WCG) impending buyout of Aetna's Medicare business to expand and cement its foothold in the rapidly growing market.

WCG AET UNH CVS

Zacks Equity Research

Aetna a Step Closer to CVS Merger, Sells Medicare Business

Aetna (AET) gets a step closer to its merger with CVS Health by selling its Medicare business to WellCare Health.

AET WCG CVS ESRX

Zacks Equity Research

Aetna Inks Deals to Improve Patient Care in Philadelphia

Aetna (AET) collaborates with Oak Street Health and ChenMed for enhancing the experience of its Medicare members in the Philadelphia market.

WCG ANTM GTS AET

Zacks Equity Research

Cigna Moves Closer to Express Scripts Buyout With DoJ Nod

Cigna (CI) clears a significant regulatory hurdle with regards to its proposed acquisition of Express Scripts.

CI AET CVS ESRX

Zacks Equity Research

Abbott's DRG Therapy Now Covered by Aetna, To Boost Uptake

Abbott (ABT) to see a rise in customer adoption of its DRG therapy following the receipt of new national coverage from Aetna.

ABT ITGR ISRG AET

Zacks Equity Research

Molina Healthcare Surges 80% YTD: Can the Rally Continue?

Molina Healthcare (MOH) gains from its rebounding endeavors and a niche positioning in the Medicaid market.

ANTM MOH AET UNH

Zacks Equity Research

Anthem Ties Up With Walmart to Better Serve Medicare Members

Anthem (ANTM) teams up with Walmart to provide medical supplies across its counter.

AET HUM UNH ANTM

Zacks Equity Research

Aetna (AET) Reaches 52-Week High on a Solid Second Quarter

Aetna's (AET) shares scale a 52-week high on Aug 17, 2018 led by strong second-quarter performance.

AET UNH WCG ANTM

Zacks Equity Research

Aetna Launches Scheme for Better Patient Care Amenities

Aetna (AET) proposes a new regional plan to serve employers better.

AET HUM WCG ANTM